What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Heart failure
- Cardiology
Barry M. Massie mainly focuses on Heart failure, Internal medicine, Cardiology, Ejection fraction and Intensive care medicine.
He has researched Heart failure in several fields, including Placebo, Heart disease, Randomized controlled trial and Sudden death.
His Internal medicine study frequently intersects with other fields, such as Surgery.
His Cardiology study frequently draws connections between adjacent fields such as Blood pressure.
His studies in Ejection fraction integrate themes in fields like Anesthesia and Irbesartan.
In his research on the topic of Intensive care medicine, Anemia is strongly related with Diabetes mellitus.
His most cited work include:
- Irbesartan in patients with heart failure and preserved ejection fraction (1312 citations)
- Single-Drug Therapy for Hypertension in Men -- A Comparison of Six Antihypertensive Agents with Placebo (1055 citations)
- Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure. (1023 citations)
What are the main themes of his work throughout his whole career to date?
Barry M. Massie mainly investigates Internal medicine, Cardiology, Heart failure, Ejection fraction and Intensive care medicine.
His study connects Surgery and Internal medicine.
His Cardiology research incorporates themes from Anesthesia, Irbesartan and Diastole.
His Heart failure research focuses on subjects like Renal function, which are linked to Creatinine.
His Ejection fraction research includes themes of Mortality rate, Digoxin, Proportional hazards model and Hazard ratio.
Barry M. Massie combines subjects such as Nesiritide, Emergency medicine and Acute decompensated heart failure with his study of Intensive care medicine.
He most often published in these fields:
- Internal medicine (90.33%)
- Cardiology (78.44%)
- Heart failure (71.19%)
What were the highlights of his more recent work (between 2009-2021)?
- Heart failure (71.19%)
- Internal medicine (90.33%)
- Cardiology (78.44%)
In recent papers he was focusing on the following fields of study:
Barry M. Massie spends much of his time researching Heart failure, Internal medicine, Cardiology, Intensive care medicine and Ejection fraction.
Barry M. Massie interconnects Placebo, Clinical trial, Surgery and Heart disease in the investigation of issues within Heart failure.
In the field of Internal medicine, his study on Hazard ratio, Renal function and Confidence interval overlaps with subjects such as Rolofylline and In patient.
His work focuses on many connections between Cardiology and other disciplines, such as Irbesartan, that overlap with his field of interest in Ventricular Ejection Fraction.
Barry M. Massie has included themes like Odds ratio, Epidemiology, Clinical course, Emergency medicine and Transplantation in his Intensive care medicine study.
His research in Ejection fraction tackles topics such as Blood pressure which are related to areas like Blood urea nitrogen.
Between 2009 and 2021, his most popular works were:
- Effect of nesiritide in patients with acute decompensated heart failure. (942 citations)
- Effect of nesiritide in patients with acute decompensated heart failure. (942 citations)
- Aliskiren, ALTITUDE, and the implications for ATMOSPHERE (681 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Heart failure
- Cardiology
Barry M. Massie mostly deals with Heart failure, Internal medicine, Cardiology, Intensive care medicine and Ejection fraction.
His Heart failure research is multidisciplinary, incorporating elements of Endocrinology, Heart disease, Enalapril and Clinical trial.
His research is interdisciplinary, bridging the disciplines of Placebo and Internal medicine.
His Cardiology research is multidisciplinary, incorporating perspectives in Clinical endpoint, Surgery and Cohort.
His studies deal with areas such as Quality of care, Epidemiology and Medical emergency as well as Intensive care medicine.
His biological study spans a wide range of topics, including Sinus rhythm and Irbesartan.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
